Your browser doesn't support javascript.
loading
Long-Term Efficacy and Safety of Low-Dose Rituximab in Patients with Refractory Myasthenia Gravis.
Ren, Jingru; Wang, Jianchun; Liu, Ran; Jin, Yunyi; Guo, Jing; Yao, Yan; Luo, Jingjing; Hao, Hongjun; Gao, Feng.
Afiliação
  • Ren J; Department of Neurology, Peking University First Hospital, Beijing, China, rjr0177@163.com.
  • Wang J; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Liu R; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Jin Y; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Guo J; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Yao Y; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Luo J; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Hao H; Department of Neurology, Peking University First Hospital, Beijing, China.
  • Gao F; Department of Neurology, Peking University First Hospital, Beijing, China.
Eur Neurol ; 86(6): 387-394, 2023.
Article em En | MEDLINE | ID: mdl-37778340
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores Imunológicos / Miastenia Gravis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur Neurol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores Imunológicos / Miastenia Gravis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur Neurol Ano de publicação: 2023 Tipo de documento: Article